GER · —

Orange S.A. (FTE.DE) Stock

$14.48 +0.07% GER: FTE.DE —

—

Valuation

MetricValue
Price$14.48
Market Cap—
P/E Ratio—
P/B Ratio—
P/S Ratio—
EPS (TTM)—
52-Week High$18.79
52-Week Low$13.50
Dividend Yield—

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity—
Current Ratio—

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield—
Quick Ratio—
Interest Coverage—
Return 1Y9.77%
Return 3Y58.55%
Return 5Y103.62%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $348.22 +1.23% 38.93 $5.08T 0.32%
MSFTMicrosoft Corporation $521.08 -2.23% 28.68 $3.87T 0.76%
GOOGLAlphabet Inc. $324.22 -3.15% 16.94 $3.94T 0.26%
AMZNAmazon.com, Inc. $250.38 -4.57% 19.82 $2.70T 0.00%
METAMeta Platforms, Inc. $648.85 -6.98% 27.93 $1.65T 0.28%

About Orange S.A.

—

Orange S.A. is led by CEO Christel Heydemann, employs 123,503 people, headquartered in Issy-les-Moulineaux, FR, publicly traded since 2007.

over the past 52 weeks the stock has ranged between $13.50 and $18.79, and currently trades 22.9% below its 52-week high.

Official website: www.orange.com

Orange S.A. (FTE.DE) — frequently asked questions

What is Orange S.A. (FTE.DE) stock price today?

Orange S.A. (FTE.DE) is currently trading at $14.48, up 0.07% today.

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% EROC ERock, Inc. $8.28 -12.01% PSQL Pasqal Holding SA $5.65 -8.28% SGP SpyGlass Pharma, Inc. $28.22 +1.84% FCBM First Carolina Financial Services, Inc. $12.91 +2.22% KPET KPET Ultra Paceline Corporation $10.00 +0.10% SHOT RMG ML Sports Holdings $9.88 +0.20% GOW GOWell Energy Technology $3.30 +1.23% QMLS QumulusAI, Inc. $3.41 -8.33%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.